People · Operator
Named in public records as an officer, director or promoter · active 2010–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Quantalife Inc | — | Biotechnology | Series B | $36.2M | $141.2M | 2010 |
Michael Y. Lucero at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Y. Lucero on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael J. Moniz | 1 | 3 |
| Paul A. Conley | 1 | 3 |
| Christopher T Blisard | 1 | 2 |
| Bill W. Colston | 1 | 2 |
| Benjamin J. Hindson | 1 | 1 |
| Kevin Y. Ness | 1 | 1 |
| Isaac Y. Bright | 1 | 1 |
| Serge Y. Saxonov | 1 | 1 |
| William W Colston | 1 | 1 |
| Peter-Christian Olivo | 1 | 1 |
| Fred P. Milanovich | 1 | 1 |
| Paul K. Kidman | 1 | 1 |
| Richard A. Ding | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.